BOONE CAPITAL MANAGEMENT LLC - Stock Holdings in 13F Filings (SEC)
Updated on March 15, 2026.
Based on 13F Filings filed with the SEC on February 17, 2026, for the 2025 Q4 period, BOONE CAPITAL MANAGEMENT LLC held in its portfolio 15 assets valued at $318,612,951 (i.e. $318.61M).
The most valuable assets in the portfolio included: MEDTRONIC PLC ($41.19M), MIRUM PHARMACEUTICALS INC ($33.27M), and IONIS PHARMACEUTICALS INC ($33.06M).
The chart below shows the top 10 valuable assets, and the table below shows the top 15 valuable assets.
You can see similar for other investment managers.
Related Topics: SEC Topic List.
Data Source: SEC.
BOONE CAPITAL MANAGEMENT LLC - Stock Holdings in 13F Filings (SEC)
Items per page:
25
0 of 0
| Name of Issuer | No. of Shares | Value ($) | Class |
|---|---|---|---|
| MEDTRONIC PLC | 428789 | 41189471 | SHS |
| MIRUM PHARMACEUTICALS INC | 421236 | 33273432 | COM |
| IONIS PHARMACEUTICALS INC | 417833 | 33054769 | COM |
| THE CIGNA GROUP | 96453 | 26546759 | COM |
| BIOMARIN PHARMACEUTICAL INC | 411880 | 24478028 | COM |
| NEUROCRINE BIOSCIENCES INC | 151815 | 21531921 | COM |
| UNITEDHEALTH GROUP INC | 61762 | 20388254 | COM |
| ASTRAZENECA PLC | 220201 | 20243078 | SPONSORED ADR |
| HEALTHEQUITY INC | 212856 | 19499738 | COM |
| LIVANOVA PLC | 288895 | 17775709 | SHS |
| RAPT THERAPEUTICS INC | 470456 | 15934345 | COM NEW |
| BRIDGEBIO PHARMA INC | 184963 | 14147820 | COM |
| KODIAK SCIENCES INC | 503830 | 14087087 | COM |
| TYRA BIOSCIENCES INC | 398482 | 10476092 | COM |
| WAVE LIFE SCIENCES LTD | 352144 | 5986448 | SHS |